Reckitt Ben. Gp Share Price (RKT)

Strong results and good prospects going forward. Strong BUY at this price.

Strong brand names, quality products and good margins are all playing their part in a good trading update and are helping the company navigate the choppy waters out there.

On an otherwise largely red day for my portfolio.

Good couple of days, that's for sure. Barclays sound bullish... potential 50% upside from here...

"Reckitt Benckiser moved to the top of the risers after a bullish update from Barclays.

Over the counter sales this quarter should be strong it said, driven by a strong flu season and easy comparison to a year ago.

Nielsen market data suggests high double-digit, or even triple-digit, growth in cold and flu treatment Mucinex.

Added to consumers switching away from rival Abbott, this could potentially add 4% to group organic sales and 6% to EPS this year.

Nielsen data suggests strong growth for the quarter, but this may include an element of retailer destocking and consumer pantry-loading.

Reckitt’s product mix and operational gearing meanwhile should also help offset headwinds from rising oil prices, even with low visibility.

The share price target is 9,100p against 6,032p, up 3.4% today."

Nice SP rise back to 60xx with a lot more to go. With inflation high big global companies like RKT and ULVR have superior buying power. They also have pricing power at the supermarkets, ability to bid for aisle end visibility and BOGOF offers. Brands will always do well over supermarket own rubbish - even better when inflation is high.